Cardiol Therapeutics, Inc. (CRDL)
2.29
+0.07
(+3.15%)
USD |
NASDAQ |
Sep 09, 16:00
2.32
+0.03
(+1.31%)
After-Hours: 17:10
Cardiol Therapeutics Total Liabilities (Quarterly) : 3.756M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.756M |
| March 31, 2026 | 5.162M |
| December 31, 2025 | 4.189M |
| September 30, 2025 | 2.434M |
| June 30, 2025 | 5.958M |
| March 31, 2025 | 5.466M |
| December 31, 2024 | 4.961M |
| September 30, 2024 | 5.247M |
| June 30, 2024 | 8.003M |
| March 31, 2024 | 8.178M |
| December 31, 2023 | 6.411M |
| September 30, 2023 | 6.052M |
| June 30, 2023 | 6.362M |
| March 31, 2023 | 5.268M |
| December 31, 2022 | 7.253M |
| September 30, 2022 | 7.046M |
| June 30, 2022 | 8.848M |
| March 31, 2022 | 8.181M |
| Date | Value |
|---|---|
| December 31, 2021 | 9.214M |
| September 30, 2021 | 2.089M |
| June 30, 2021 | 2.433M |
| March 31, 2021 | 2.275M |
| December 31, 2020 | 2.059M |
| September 30, 2020 | 1.484M |
| June 30, 2020 | 0.9649M |
| March 31, 2020 | 0.5806M |
| December 31, 2019 | 0.6407M |
| September 30, 2019 | 1.252M |
| June 30, 2019 | 0.7271M |
| March 31, 2019 | 0.7312M |
| December 31, 2018 | 1.765M |
| September 30, 2018 | 10.70M |
| June 30, 2018 | 8.529M |
| March 31, 2018 | |
| December 31, 2017 | 0.2927M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 2.242M |
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
| Clearmind Medicine, Inc. | 3.033M |
| Lexaria Bioscience Corp. | 0.4371M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.69M |
| Shareholders Equity (Quarterly) | 16.94M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 5.553 |
| Net Debt Paydown Yield | 0.00% |